Synaptogenix, Inc.

NasdaqCM:SNPX Rapporto sulle azioni

Cap. di mercato: US$4.0m

Synaptogenix Crescita futura

Future criteri di controllo 0/6

Synaptogenix's earnings are forecast to decline at 37.6% per annum. EPS is expected to decline by 0.5% per annum.

Informazioni chiave

-37.6%

Tasso di crescita degli utili

-0.5%

Tasso di crescita dell'EPS

Biotechs crescita degli utili27.1%
Tasso di crescita dei ricavin/a
Rendimento futuro del capitale proprion/a
Copertura analitica

Low

Ultimo aggiornamento11 Jul 2024

Aggiornamenti recenti sulla crescita futura

Nessun aggiornamento

Recent updates

We Think Synaptogenix (NASDAQ:SNPX) Can Afford To Drive Business Growth

Sep 20
We Think Synaptogenix (NASDAQ:SNPX) Can Afford To Drive Business Growth

Companies Like Synaptogenix (NASDAQ:SNPX) Are In A Position To Invest In Growth

May 10
Companies Like Synaptogenix (NASDAQ:SNPX) Are In A Position To Invest In Growth

Synaptogenix: High-Risk High-Reward For Potential Alzheimer's Disease Treatment

Nov 17

Synaptogenix (NASDAQ:SNPX) Is In A Good Position To Deliver On Growth Plans

Oct 05
Synaptogenix (NASDAQ:SNPX) Is In A Good Position To Deliver On Growth Plans

Synaptogenix: The Next Big Thing In Alzheimer's

Jun 16

Synaptogenix provides update on phase 2b Alzheimer's disease trial

Jun 09

We're Keeping An Eye On Synaptogenix's (NASDAQ:SNPX) Cash Burn Rate

Jun 09
We're Keeping An Eye On Synaptogenix's (NASDAQ:SNPX) Cash Burn Rate

Previsioni di crescita degli utili e dei ricavi

NasdaqCM:SNPX - Stime future degli analisti e dati finanziari passati (USD Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/2026N/A-21N/AN/A1
12/31/2025N/A-13N/AN/A1
12/31/2024N/A-8N/AN/A1
6/30/2024N/A-3-5-5N/A
3/31/2024N/A-12-5-5N/A
12/31/2023N/A-14-5-5N/A
9/30/2023N/A-8-7-7N/A
6/30/2023N/A-11-8-8N/A
3/31/2023N/A-4-9-9N/A
12/31/2022N/A-6-11-11N/A
9/30/2022N/A-14-10-10N/A
6/30/2022N/A-14-9-9N/A
3/31/2022N/A-13-9-9N/A
12/31/2021N/A-13-9-9N/A
9/30/2021N/A-14-8-8N/A
6/30/2021N/A-15-10-10N/A
3/31/2021N/A-16-10-10N/A
12/31/2020N/A-15-8-8N/A
9/30/2020N/A-12-8-8N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: SNPX is forecast to remain unprofitable over the next 3 years.

Guadagni vs Mercato: SNPX is forecast to remain unprofitable over the next 3 years.

Guadagni ad alta crescita: SNPX is forecast to remain unprofitable over the next 3 years.

Ricavi vs Mercato: Insufficient data to determine if SNPX's revenue is forecast to grow faster than the US market.

Ricavi ad alta crescita: SNPX is forecast to have no revenue next year.


Previsioni di crescita dell'utile per azione


Rendimento futuro del capitale proprio

ROE futuro: Insufficient data to determine if SNPX's Return on Equity is forecast to be high in 3 years time


Scoprire le aziende in crescita